Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health
CCR - For Our Staff| Home |

Our Science – Ward Website

Yvona Ward, Ph.D.

Portait Photo of Yvona Ward
Laboratory of Genitourinary Cancer Pathogenesis
Head, Microscopy Core Facility
Staff Scientist
Center for Cancer Research
National Cancer Institute
Building 37, Room 1066
Bethesda, MD 20892


Dr. Yvona Ward received her Ph.D. in 1992 from the University of Waterloo, Ontario, Canada. She then joined Dr. Kathy Kelly in the Laboratory of Pathology at the NCI where she conducted studies on PAC-1, a MAP Kinase phosphatase and investigated the role of the Ral pathway in tumorigenesis and metastasis. In 1999, Dr. Ward became the head of the Microinjection and Confocal Microscopy Core Facility in the Cell and Cancer Biology Branch of the NCI. Dr. Ward is currently head of the Laboratory of Genitourinary Cancer Pathogenesis Microscopy Core Facility.


The Laboratory of Genitourinary Cancer Pathogenesis Microscopy Core Facility provides training, guidance, and state-of-the-art service to scientists in the LGCP and other laboratories at the NCI who require in vivo imaging or confocal microscopy techniques as part of their research efforts. The core facility currently houses a Zeiss LSM 510 META confocal microscope capable of generating images with up to four different colors, an Olympus VivaView Fluorescence Incubator Microscope for long term live cell imaging, and a Zeiss AxioObserver.Z1 epifluorescent scope equipped with a digital camera and AxioVision software. Please refer to the Microscopy Core Facilty website using the 'Links' tab for a detailed description of equipment capability, sample images, publications, and scheduling time on the equipment.

Image acquisition and analysis is provided free of charge. Scientists who are fully trained in confocal microscopy work independently while inexperienced users are encouraged to arrange for training or to establish a collaboration with Yvona Ward.

In addition to managing the LGCP core facility, Dr. Ward conducts research in collaboration with Dr. Kathy Kelly on the role of CD97, an adhesion class GPCR, in tumor progression and metastasis.

This page was last updated on 7/10/2014.